Sign in to view content

Episode 23: CANTREAT Study. Ranibizumab Monthly vs Treat-and-Extend for wAMD with Dr. Peter Kertes

Keyvan Koushan, MD, FRCSC

Audio
Published 2019

Related

The Effect of Intravitreal Afilbercept on Perfusion Status in Patients with Retinal Vascular Disease
Jeffrey S. Heier, MD
Updates from the Field
2016
Anti-VEGF treatment switch in DME and nAMD: a comparison of aflibercept versus ranibizumab after a single-dose switch
Estephania Feria, MD
On Demand Cases, Courses, and Papers
2019
Sustained Diabetic Retinopathy Severity Improvement With Intravitreal Aflibercept in DME: Post Hoc Analysis of VISTA and VIVID
Rishi P. Singh, MD
Annual Meeting Talks
2019

Category: Age-Related Macular Degeneration

See more